CERVICAL CANCER RECURRENT

Clinical trials for CERVICAL CANCER RECURRENT explained in plain language.

Never miss a new study

Get alerted when new CERVICAL CANCER RECURRENT trials appear

Sign up with your email to follow new studies for CERVICAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New combo therapy shows promise for hard-to-treat cervical cancer

Disease control Ongoing

This study tested whether adding a precise type of radiation (SBRT) to an immunotherapy drug (atezolizumab) could shrink tumors better than the drug alone in people with cervical cancer that has come back or spread. The trial enrolled 21 adults with recurrent, persistent, or meta…

Matched conditions: CERVICAL CANCER RECURRENT

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated May 14, 2026 12:04 UTC

CERVICAL CANCER RECURRENT

Get alerted when new CERVICAL CANCER RECURRENT trials appear

New combo therapy shows promise for hard-to-treat cervical cancer